The hardened criminals were among some of those due to be returned from the 1,200-strong Albanian population in British prisons – but only 67 lags have been nominated to go. The two-year scheme ...
MSD has decided to abandon the development of its anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline. The demise of the two ...